Home
For applicants
For doctors
For patients
Training and events

Professional development Vacancies

UKR
EN

Professional development Vacancies

Sections Search Consultation Accessibility

Home
For doctors
Pharmacovigilance
Current safety information on medicinal products
Important information on the risks of using VALPROATES in women of childbearing potential and pregnant women

Important information on the risks of using VALPROATES in women of childbearing potential and pregnant women

13.10.2022 1038 views

Share

Messengers

Telegram Viber WhatsApp Messenger

Social networks

Facebook LinkedIn X Threads

Other

Email

Point your phone camera to open this page on it

Other materials in this section

17.08.2026The European Medicines Agency (EMA) starts a review of medicinal products containing ipidacrine
28.07.2026Changes to the safety information of medicinal products containing amikacin (amikacin) based on the results of the meeting of the Pharmacovigilance Risk Assessment Committee (PRAC) of 04 – 07 May 2026
28.07.2026Changes to the safety information for medicinal products containing tobramycin based on the results of the Pharmacovigilance Risk Assessment Committee (PRAC) meeting of 04 – 07 May 2026
28.07.2026Changes to the safety information of medicinal products containing trabectedin following the meeting of the Pharmacovigilance Risk Assessment Committee (PRAC) of 04 – 07 May 2026
28.07.2026On amending the package leaflets of medicinal products containing metronidazole / neomycin / nystatin (metronidazole / neomycin / nystatin)

All 180 of the materials in the section

Useful resources

Register of medical technological documents
State Formulary of Medicinal Products
Actions of the population in emergency situations of a military nature State Emergency Service of Ukraine (will open on another website)

Pharmacovigilance (for healthcare professionals)

Current safety information on medicinal products
Regulatory legal acts on pharmacovigilance
Reporting forms for adverse reactions and/or lack of efficacy of medicinal products in their medical use
Immunoprophylaxis
- Immunoprophylaxis
- Safety of vaccines against COVID-19
Results of activities on medicinal product safety
Summary of the Risk Management Plan
Letters — communications to healthcare and pharmaceutical professionals
- Letters — communications to healthcare and pharmaceutical professionals
- 2025
- 2024
- 2023
- 2022
- 2021
- 2020
- 2019
- 2018
- 2017
- 2016
Decisions and recommendations of regulatory agencies

Conferences, Forums, Events

Forum "PHARMEXPERT 2026: pharmaceutical market in the new regulatory reality"

Forum "PHARMEXPERT 2026: pharmaceutical market in the new regulatory reality"

Forum "Clinical and preclinical studies in wartime: organization and development prospects"

Forum "Clinical and preclinical studies in wartime: organization and development prospects"

Pharmaceutical forum "PHARMEXPERT 2025. eCTD and pricing in Ukraine – a strategic path to integration into the international regulatory space"

Pharmaceutical forum "PHARMEXPERT 2025. eCTD and pricing in Ukraine – a strategic path to integration into the international regulatory space"

PHARMEXPERT 2024. Standards. Innovations. European integration

PHARMEXPERT 2024. Standards. Innovations. European integration

View all

Latest updates

Картка пацієнта щодо безпеки застосування лікарського засобу ТЕПКІНЛІ (епкорітамаб)

# For doctors # Pharmacovigilance # Letters — communications to medical and pharmaceutical professionals # 2026

Read more

Картка пацієнта щодо безпеки застосування лікарського засобу ТЕПКІНЛІ (епкорітамаб)

# For patients # Pharmacovigilance # Letters — communications to patients # 2026

Read more

Інформаційний лист-звернення до спеціалістів сфери охорони здоров’я щодо безпеки застосування лікарських засобів НОВАРИНГ®, МАРВЕЛОН®, ІМПЛАНОН® НКСТ. Лікарські засоби, що містять дезогестрел та етонгестрел: ризик менінгіоми та заходи для мінімізації ризику

# For doctors # Pharmacovigilance # Letters — communications to medical and pharmaceutical professionals # 2026

Read more

List of substantial amendments to clinical trial protocols NER No. 35, NTR No. 41 of 15.10.2026

# Заявникам # Експертиза матеріалів доклінічних та клінічних випробувань # Перелік протоколів клінічних випробувань лікарських засобів, рекомендованих до затвердження МОЗ

Read more

List of medicinal products registered by competent authorities (12.10.2026 – 13.10.2026)

# Заявникам # Переліків ЛЗ, які зареєстровані компетентними органами

Read more

All updates for today

Latest Announcements

Updated! Competitive selection of members of the Expert Committee on HTA: deadline for submitting documents – until October 23, 2026

More details

Updated! List of original (innovative) medicinal products registered in Ukraine as of 07.09.2026

More details

Attention to business entities engaged in retail trade of medicinal products on the market of Ukraine! We provide lists of over-the-counter medicinal products by their storage conditions

More details

All Announcements

Latest News

ДЕЦ та «Феофанія» розвивають співпрацю: фахівці лікарні отримали сертифікати з GCP

ДЕЦ та «Феофанія» розвивають співпрацю: фахівці лікарні отримали сертифікати з GCP

More details

Етелкальцетид для лікування вторинного гіперпаратиреозу: нова рекомендація ДЕЦ

Етелкальцетид для лікування вторинного гіперпаратиреозу: нова рекомендація ДЕЦ

More details

A new clinical protocol of medical care for iron deficiency anemia has been approved in Ukraine

A new clinical protocol of medical care for iron deficiency anemia has been approved in Ukraine

More details

All News

Statistics

List of applications for state registration of medicinal products
List of medicinal products recommended for registration, re-registration and amendments to registration materials
List of medicinal products for which the expert evaluation of the authenticity of registration materials has been completed

Sections

State Expert Center
History
ISO 9001:2015

Tools

Contacts
Frequently asked questions/FAQ

Contacts

Enterprise address:

03057, Kyiv, Simi Brodskykh St., 10 (Smolenska St., 10)

+38 (044) 202-17-00

Service Center:

+38 (044) 202-17-05

Accounting:

+38 (044) 202-17-06

Single Window:

+38 (044) 202-17-09

In case of full or partial use of the information posted on the website, a reference to the source of information is mandatory. All materials and documentation presented are for informational purposes and cannot be used as official documents. Commercial use of the information is prohibited without written permission. If inaccuracies are found in the information posted on the website, please notify the website support service at support@dec.gov.ua

All rights reserved 1990 - 2026 www.dec.gov.ua

Online consultation

Website

Full name *

E-mail *

Structural subdivision *

Applicant

Manufacturer

Message *

Application for participation in the seminar

*

*

*

*

*

*

*

*

Application for participation in training

*

*

*

*

*

*

*

Feedback

*

*

Anti-corruption

In order to prevent manifestations of corruption

By the state enterprise

"State Expert Center of the Ministry of Health of Ukraine"

a special telephone line has been introduced, through which messages are accepted at the number

(050) – 630 – 23 – 60

The Ministry of Health of Ukraine has a Authorized Unit for the Prevention and Detection of Corruption

Contact phone - (044) – 253 – 60 – 22

E-mail - zpk@moz.gov.ua

Whistleblower Portal